Munding, Jay Ann F.

HRN: 21-81-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2022
AMPICILLIN 1GM (VIAL)
08/14/2022
08/15/2022
IV
1g
Q6hrs
PROM
Waiting Final Action 
08/14/2022
AMPICILLIN 1GM (VIAL)
08/14/2022
08/15/2022
IV
1g
Q6hrs
PROM
Waiting Final Action 
08/14/2022
CEFUROXIME 500MG (TAB)
08/14/2022
08/20/2022
ORAL
500mg
BID
PROM S/P NSVD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: